Human PAFAH1B2/HEL-S-303 ORF/cDNA clone-Mammalian (Non-Viral Vector) plasmid (NM_002572.4)
Cat. No.: pGMPC001137
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human PAFAH1B2/HEL-S-303 Non-Viral expression plasmid (overexpression vector) for mouse PAFAH1B2 overexpression in unique cell transient transfection and stable cell line development.
Go to
PAFAH1B2/HEL-S-303 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMPC001137 |
| Gene Name | PAFAH1B2 |
| Accession Number | NM_002572.4 |
| Gene ID | 5049 |
| Species | Human |
| Product Type | Mammalian (Non-Viral Vector) plasmid (overexpression) |
| Insert Length | 690 bp |
| Gene Alias | HEL-S-303 |
| Fluorescent Reporter | EGFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGAGCCAAGGAGACTCAAACCCAGCAGCTATTCCGCATGCAGCAGAAGATATTCAAGGAGATGACCGATGGATGTCTCAGCACAACAGATTTGTTTTGGACTGTAAAGACAAAGAGCCTGATGTACTGTTCGTGGGAGACTCCATGGTGCAGTTAATGCAGCAATATGAGATATGGCGAGAGCTTTTTTCCCCACTTCATGCACTGAATTTTGGAATTGGGGGAGATACAACAAGACATGTTTTGTGGAGACTAAAGAATGGAGAACTGGAGAATATTAAGCCTAAGGTCATTGTTGTCTGGGTAGGAACAAATAACCACGAAAATACAGCAGAAGAAGTAGCAGGTGGGATCGAGGCCATTGTACAACTTATCAACACAAGGCAGCCACAGGCCAAAATCATTGTATTGGGTTTGTTACCTCGAGGTGAGAAACCCAATCCTTTGAGGCAAAAGAACGCCAAGGTGAACCAACTCCTCAAGGTTTCGCTGCCGAAGCTTGCCAACGTGCAGCTCCTGGATACCGACGGGGGTTTTGTGCACTCGGACGGTGCCATCTCCTGCCACGACATGTTTGATTTTCTGCATCTGACAGGAGGGGGCTATGCAAAGATCTGCAAACCCCTGCATGAACTGATCATGCAGTTGTTGGAGGAAACACCTGAGGAGAAACAAACCACCATTGCCTGA |
| ORF Protein Sequence | MSQGDSNPAAIPHAAEDIQGDDRWMSQHNRFVLDCKDKEPDVLFVGDSMVQLMQQYEIWRELFSPLHALNFGIGGDTTRHVLWRLKNGELENIKPKVIVVWVGTNNHENTAEEVAGGIEAIVQLINTRQPQAKIIVLGLLPRGEKPNPLRQKNAKVNQLLKVSLPKLANVQLLDTDGGFVHSDGAISCHDMFDFLHLTGGGYAKICKPLHELIMQLLEETPEEKQTTIA |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-MP2229-Ab | Anti-PA1B2/ PAFAH1B2/ HEL-S-303 monoclonal antibody |
| Target Antigen | GM-Tg-g-MP2229-Ag | PAFAH1B2 VLP (virus-like particle) |
| ORF Viral Vector | pGMLP002441 | Human PAFAH1B2 Lentivirus plasmid |
| ORF Viral Vector | pGMPC001137 | Human PAFAH1B2 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | vGMLP002441 | Human PAFAH1B2 Lentivirus particle |
Target information
| Target ID | GM-MP2229 |
| Target Name | PAFAH1B2 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
5049 |
| Gene ID |
100062620 (Equus caballus), 101085656 (Felis catus), 119881476 (Canis lupus familiaris), 18475 (Mus musculus) 282514 (Bos taurus), 5049 (Homo sapiens), 64189 (Rattus norvegicus), 703013 (Macaca mulatta) |
| Gene Symbols & Synonyms | PAFAH1B2,Pafah1b2,Pafahb,mus[b],2610005M20Rik,PAFAH1B2P68402,HEL-S-303 |
| Target Alternative Names | 2610005M20Rik,HEL-S-303,PAF acetylhydrolase 30 kDa subunit (PAF-AH 30 kDa subunit),PAF-AH subunit beta (PAFAH subunit beta),PAFAH1B2,PAFAH1B2P68402,Pafah1b2,Pafahb,Platelet-activating factor acetylhydrolase IB subunit alpha2,mus[b] |
| Uniprot Accession |
O35264,P68401,P68402,Q61206
Additional SwissProt Accessions: Q61206,P68401,P68402,O35264 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | |
| Disease | cancer |
| Disease from KEGG | Metabolic pathways, Ether lipid metabolism |
| Gene Ensembl | ENSECAG00000034204, ENSCAFG00845004183, ENSMUSG00000003131, ENSBTAG00000005627, ENSG00000168092, ENSMMUG00000002050 |
| Target Classification | Tumor-associated antigen (TAA) |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


